Detalhe da pesquisa
1.
Hepatocyte growth factor, a determinant of airspace homeostasis in the murine lung.
PLoS Genet
; 9(2): e1003228, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23459311
2.
Monovalent antibody design and mechanism of action of onartuzumab, a MET antagonist with anti-tumor activity as a therapeutic agent.
Proc Natl Acad Sci U S A
; 110(32): E2987-96, 2013 Aug 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-23882082
3.
Tumor-cell resistance to death receptor--induced apoptosis through mutational inactivation of the proapoptotic Bcl-2 homolog Bax.
Nat Med
; 8(3): 274-81, 2002 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-11875499
4.
Cooperation of the agonistic DR5 antibody apomab with chemotherapy to inhibit orthotopic lung tumor growth and improve survival.
Clin Cancer Res
; 14(23): 7733-40, 2008 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19047100
5.
Imaging tumors with an albumin-binding Fab, a novel tumor-targeting agent.
Cancer Res
; 67(1): 254-61, 2007 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17210705
6.
Somatic mutations lead to an oncogenic deletion of met in lung cancer.
Cancer Res
; 66(1): 283-9, 2006 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16397241
7.
A novel one-armed anti-c-Met antibody inhibits glioblastoma growth in vivo.
Clin Cancer Res
; 12(20 Pt 1): 6144-52, 2006 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17062691
8.
Inhibition of ligand-mediated HER2 activation in androgen-independent prostate cancer.
Cancer Res
; 62(19): 5485-8, 2002 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-12359757
9.
Selective cyclin-dependent kinase 2/cyclin A antagonists that differ from ATP site inhibitors block tumor growth.
Cancer Res
; 63(5): 1020-4, 2003 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-12615717
10.
Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand cooperates with chemotherapy to inhibit orthotopic lung tumor growth and improve survival.
Cancer Res
; 64(14): 4900-5, 2004 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-15256461
11.
HER2-targeted therapy reduces incidence and progression of midlife mammary tumors in female murine mammary tumor virus huHER2-transgenic mice.
Clin Cancer Res
; 10(7): 2499-511, 2004 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15073130
12.
Improved gene transfer selectivity to hepatocarcinoma cells by retrovirus vector displaying single-chain variable fragment antibody against c-Met.
Cancer Gene Ther
; 10(11): 840-9, 2003 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-14605670
13.
The therapeutic potential of hepatocyte growth factor for myocardial infarction and heart failure.
Curr Pharm Des
; 10(20): 2525-33, 2004.
Artigo
em Inglês
| MEDLINE | ID: mdl-15320761
14.
MetMAb, the one-armed 5D5 anti-c-Met antibody, inhibits orthotopic pancreatic tumor growth and improves survival.
Cancer Res
; 68(11): 4360-8, 2008 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18519697
15.
Quantification of viable tumor microvascular characteristics by multispectral analysis.
Magn Reson Med
; 60(1): 64-72, 2008 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-18421695
16.
Targeting HER2-positive breast cancer with trastuzumab-DM1, an antibody-cytotoxic drug conjugate.
Cancer Res
; 68(22): 9280-90, 2008 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19010901
17.
Early treatment with hepatocyte growth factor improves cardiac function in experimental heart failure induced by myocardial infarction.
J Pharmacol Exp Ther
; 304(2): 654-60, 2003 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-12538818
18.
Quantification of tumor tissue populations by multispectral analysis.
Magn Reson Med
; 51(3): 542-51, 2004 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-15004796
19.
Stanniocalcin 1 is an autocrine modulator of endothelial angiogenic responses to hepatocyte growth factor.
J Biol Chem
; 278(48): 47654-9, 2003 Nov 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-14500721
20.
Hepatocyte growth factor receptor in acute tubular necrosis.
J Am Soc Nephrol
; 12(3): 531-540, 2001 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-11181801